Cargando…
Rationally Designed Bicyclic Peptides Prevent the Conversion of Aβ42 Assemblies Into Fibrillar Structures
There is great interest in drug discovery programs targeted at the aggregation of the 42-residue form of the amyloid β peptide (Aβ42), since this molecular process is closely associated with Alzheimer’s disease. The use of bicyclic peptides may offer novel opportunities for the effective modificatio...
Autores principales: | Ikenoue, Tatsuya, Aprile, Francesco A., Sormanni, Pietro, Vendruscolo, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947257/ https://www.ncbi.nlm.nih.gov/pubmed/33716651 http://dx.doi.org/10.3389/fnins.2021.623097 |
Ejemplares similares
-
A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease
por: Ikenoue, Tatsuya, et al.
Publicado: (2020) -
A Rationally Designed Hsp70 Variant Rescues the Aggregation-Associated Toxicity of Human IAPP in Cultured Pancreatic Islet β-Cells
por: Bongiovanni, Marie Nicole, et al.
Publicado: (2018) -
Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
por: Aprile, Francesco A., et al.
Publicado: (2017) -
Polymorphism of fibrillar structures depending on the size of assembled Aβ(17-42) peptides
por: Cheon, Mookyung, et al.
Publicado: (2016) -
Computational maturation of a single-domain antibody against Aβ42 aggregation
por: Lin, Jiacheng, et al.
Publicado: (2021)